GDS Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7M Buy
7,607
+6,722
+760% +$6.81M 0.42% 69
2025
Q4
$951K Buy
885
+497
+128% +$475K 0.06% 94
2025
Q3
$296K Buy
388
+32
+9% +$23.8K 0.02% 151
2025
Q2
$278K Buy
356
+13
+4% +$10.1K 0.02% 148
2025
Q1
$283K Buy
+343
New +$285K 0.02% 141
2024
Q3
Sell
-265
Closed -$240K 172
2024
Q2
$240K Buy
+265
New +$212K 0.03% 119

Other funds holding LLY

GDS Wealth Management's LLY Position: Q1 2026 in Review

GDS Wealth Management increased its Eli Lilly (LLY) stake by 760% in Q1 2026, buying an estimated $6.81M and bringing the position to 7,607 shares worth $7M. The position accounts for 0.42% of the portfolio, ranked #69.

GDS Wealth Management first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • GDS Wealth Management held 7,607 shares of Eli Lilly worth $7M as of Q1 2026.
  • GDS Wealth Management bought 6,722 Eli Lilly shares in Q1 2026, an estimated $6.81M.
  • Eli Lilly made up 0.42% of GDS Wealth Management's portfolio in Q1 2026, its #69 holding.
  • GDS Wealth Management first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on GDS Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.